antimalaria < antimalarial < antimalarials

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 108.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000001 (2011)	Ilan Ben-Zvi [Israël] ; Shaye Kivity [Israël] ; Pnina Langevitz [Israël] ; Yehuda Shoenfeld [Israël]	Hydroxychloroquine: From Malaria to Autoimmunity
000005 (2007)	Sunil Kalia ; Jan P. Dutz	New concepts in antimalarial use and mode of action in dermatology
000010 (2006)	Vicente Giner Galva [Espagne] ; María Rosa Oltra [Espagne] ; Diego Rueda [Espagne] ; María José Esteban [Espagne] ; Josep Red N [Espagne]	Severe acute hepatitis related to hydroxychloroquine in a woman with mixed connective tissue disease
000011 (2009)	Gabriele Fragasso [Italie] ; Francesca Sanvito [Italie] ; Francesca Baratto [Italie] ; Sabina Martinenghi [Italie] ; Claudio Doglioni [Italie] ; Alberto Margonato [Italie]	Cardiotoxicity after low-dose chloroquine antimalarial therapy
000012 (1998)	Jan Bondeson [Suède] ; Roger Sundler [Suède]	Antimalarial Drugs Inhibit Phospholipase A2 Activation and Induction of Interleukin lβ and Tumor Necrosis Factor α in Macrophages: Implications for Their Mode of Action in Rheumatoid Arthritis
000014 (1988)	Harold E. Paulus [États-Unis]	Antimalarial agents compared with or in combination with other disease-modifying antirheumatic drugs
000020 (2001)	Marta J. Van Beek [États-Unis] ; Warren W. Piette [États-Unis]	Antimalarials
000027 (1988)	Naomi Rothfield [États-Unis]	Efficacy of antimalarials in systemic lupus erythematosus
000029 (2012)	N. Ezra [États-Unis] ; J. Jorizzo [États-Unis]	Hydroxychloroquine and smoking in patients with cutaneous lupus erythematosus
000070 (2000)	Andrew L. Gilman [États-Unis] ; Ka-Wah Chan [États-Unis] ; Mark Mogul [États-Unis] ; Christopher Morris [États-Unis] ; Frederick D. Goldman [États-Unis] ; Michael Boyer [États-Unis] ; Emanuel Cirenza [États-Unis] ; Amitabha Mazumder [États-Unis] ; Edmund Gehan [États-Unis] ; Richard Cahill [États-Unis] ; Stanley Frankel [États-Unis] ; Kirk Schultz [États-Unis]	Hydroxychloroquine for the treatment of chronic graft-versus-host disease
000072 (1989)	Daniel J. Wallace [États-Unis]	The use of quinacrine (Atabrine) in rheumatic diseases: A reexamination
000085 (1998)	Thomas Keller [Autriche] ; Andrea Schneider [Autriche] ; Robert Lamprecht [Autriche] ; Rolf Aderjan [Allemagne] ; Edith Tutsch-Bauer [Autriche] ; Wolfgang Kisser [Autriche]	Fatal chloroquine intoxication
000091 (2004)	S. Bernatsky ; C. A. Pinaeu ; M. Gans ; A. Clarke [Canada]	Adherence to guidelines for the monitoring of antimalarial-related retinal toxicity
000097 (2004)	P. Geraminejad [États-Unis] ; M S Stone [États-Unis] ; R D Sontheimer [États-Unis]	Antimalarial lichenoid tissue reactions in patients with pre-existing lupus erythematosus
000108 (2000)	Petra Maria Becker-Wegerich ; Annegret Kuhn ; Lucy Malek ; Percy Lehmann ; Mosaad Megahed ; Thomas Ruzicka	Treatment of nonmelanotic hyperpigmentation with the Q-switched ruby laser
000132 (1979)	Martin E. Schüpbach [Suisse]	Mutagenicity evaluation of the two antimalarial agents chloroquine and mefloquine, using a bacterial fluctuation test
000201 (2002)	Jack B. Cohen [États-Unis]	Cutaneous involvement of dermatomyositis can respond to Dapsone therapy
000209 (2003)	Chiho Ono [Japon] ; Masayoshi Yamada [Japon] ; Makoto Tanaka [Japon]	Absorption, distribution and excretion of 14C‐chloroquine after single oral administration in albino and pigmented rats: binding characteristics of chloroquine‐related radioactivity to melanin in‐vivo
000283 (1994)	E. Pussard [France] ; F. Verdier [France]	Antimalarial 4‐aminoquinolines: mode of action and pharmacokinetics
000302 (2011)	Chingching Foocharoen [Thaïlande] ; Ratanavadee Nanagara [Thaïlande] ; Siraphop Suwannaroj [Thaïlande] ; Ajanee Mahakkanukrauh [Thaïlande]	Survival rate among Thai systemic lupus erythematosus patients in the era of aggressive treatment
000345 (2012)	Eamonn S. Molloy [Irlande (pays)] ; Leonard H. Calabrese [États-Unis]	Progressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases: Evolving role of biologic therapies

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "antimalarial" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "antimalarial" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    antimalarial
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021